Trial Profile
A Safety and Pharmacokinetics Study of Single Dose Dexmedetomidine Transdermal System in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Jul 2019
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary)
- Indications Postoperative pain
- Focus Adverse reactions
- Sponsors Teikoku Pharma USA
- 22 Aug 2018 Status changed from recruiting to completed.
- 09 Feb 2018 New trial record